SCHEMBL753024

SCHEMBL753024

C[C@H](c1ccc(COc2ccc(C(=O)O)nn2)cc1Cl)[C@@](O)(c1ccnc(Cl)c1)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.38
FFAR1 O14842 3/20 0.35
KDM5A P29375 5/20 0.33
KDM4C Q9H3R0 4/20 0.33
KDM5B Q9UGL1 4/20 0.33
PTGER1 P34995 1/20 0.33
KDM2B Q8NHM5 1/20 0.32
GABRA1 P14867 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
KDM4A O75164 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479838 1.00 MRGPRX4 (0.38) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL754430 0.92 MRGPRX4 (0.33) MRGPRX4FFAR1KDM5AKDM5BGABRA1
SCHEMBL479696 0.92 MRGPRX4 (0.33) MRGPRX4FFAR1KDM5AKDM5BGABRA1
SCHEMBL15789687 0.91 FFAR1 (0.35) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL15789765 0.89 FFAR1 (0.34) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL480021 0.88 MRGPRX4 (0.38) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL752266 0.88 MRGPRX4 (0.38) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL753249 0.86 MRGPRX4 (0.41) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL734262 0.86 MRGPRX4 (0.41) MRGPRX4FFAR1KDM5AKDM4CKDM5B
SCHEMBL15789781 0.84 FFAR1 (0.34) MRGPRX4FFAR1KDM5AKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 MRGPRX4 284/4885FFAR1 45/4885KDM5A 2193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.